Should I adjust the Glargine (insulin glargine) regimen for a type 1 diabetic patient with hyperglycemia (A1c 10.9) and frequent glucose spikes, from 37 units to a split dose of 20 units in the morning and 20 units in the evening?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 1, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Insulin Regimen Adjustment for Type 1 Diabetic with Hyperglycemia

Yes, splitting the glargine dose to 20 units in the morning and 20 units in the evening is recommended for this patient with type 1 diabetes experiencing glucose spikes throughout the day. 1, 2

Rationale for Split Dosing

The patient's current regimen of sliding scale insulin plus 37 units of glargine is clearly inadequate, as evidenced by:

  • HbA1c of 10.9% (significantly above target)
  • Glucose spikes throughout the day
  • Current single daily dose may not provide consistent 24-hour coverage

Benefits of Split Dosing

  1. More consistent insulin coverage: Splitting the basal insulin provides more stable glucose levels throughout the 24-hour period 2
  2. Reduced glucose variability: Twice-daily dosing helps minimize the peaks and troughs in insulin action 2, 3
  3. Better control of fasting and pre-meal glucose: Morning dose helps control daytime glucose while evening dose controls overnight levels 1

Implementation Plan

  1. Initial dose adjustment:

    • Change from 37 units once daily to 20 units in the morning and 20 units in the evening (total 40 units)
    • The slight increase in total daily dose (3 units) is reasonable given the poor glycemic control 1
  2. Monitoring after adjustment:

    • Assess fasting plasma glucose (FPG) daily
    • Monitor pre-meal and post-meal glucose levels
    • Watch for hypoglycemia, especially during the transition period
  3. Further titration:

    • Adjust each dose separately based on glucose patterns
    • Morning dose affects daytime glucose control
    • Evening dose affects overnight and early morning glucose control
    • Follow evidence-based titration: increase by 2 units every 3 days until target glucose is reached without hypoglycemia 1

Additional Considerations

  • Sliding scale adjustment: The patient's sliding scale insulin should be continued but may need adjustment once the basal insulin regimen is optimized
  • Hypoglycemia risk: If hypoglycemia occurs, determine the cause and reduce the corresponding dose by 10-20% 1
  • Meal timing: Ensure consistent meal timing relative to insulin administration
  • Injection sites: Rotate injection sites within the same region to reduce the risk of lipodystrophy 4

Potential Pitfalls

  • Morning hypoglycemia: If morning hypoglycemia occurs, reduce the evening glargine dose
  • Pre-dinner hyperglycemia: If pre-dinner glucose remains high, consider increasing the morning glargine dose
  • Nocturnal hypoglycemia: Monitor for this common complication when adjusting basal insulin doses 3

Follow-up Plan

  • Reassess the effectiveness of the split-dose regimen within 1-2 weeks
  • Consider further adjustments based on glucose patterns
  • Evaluate the need for additional prandial insulin coverage if postprandial spikes persist despite optimized basal insulin

This approach aligns with current guidelines for insulin management in type 1 diabetes and addresses the specific issue of glucose variability throughout the day that the patient is experiencing.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.